yhingz

GemzarŽ plus Second Chemotherapy Agent Provides Small Survival Benefits in Advanced Pancreatic Cancer
According to results recently published in the journal Drugs and Aging, the combination of GemzarŽ (gemcitabine) with a second chemotherapy agent provides small but significant improvements in survival compared with Gemzar only in the treatment of metastatic pancreatic cancer.

The pancreas is an organ surrounded by the stomach, small intestine, bile ducts (tubes that connect the liver to the small intestine), gallbladder, liver, and spleen. The pancreas helps the body break down food and also produces hormones, such as insulin, to regulate the body’s storage and use of food.

Pancreatic cancer has one of the highest mortality rates of all cancers. Pancreatic cancer is often called a “silent killer” because its symptoms are usually not recognizable until it has advanced and spread outside the pancreas. As a result the majority of pancreatic cancers are not diagnosed until they have reached advanced stages and are considered incurable. Researchers continue to evaluate novel ways to treat pancreatic cancer in order to extend survival for these patients.

The chemotherapy agent Gemzar is commonly used as treatment for pancreatic cancer. The addition of a second chemotherapy agent to Gemzar, referred to as a Gemzar-based doublet, is also a common therapeutic approach for this disease. Researchers from France recently evaluated the true benefit of adding a second chemotherapy agent to Gemzar for the treatment of pancreatic cancer. The researchers conducted a study that reviewed 23 clinical trials, which included 5,886 patients with advanced pancreatic cancer; these patients had been treated with either a Gemzar-based doublet or Gemzar alone.

At six months patients treated with Gemzar-based doublets had an 8% reduced risk of death compared with patients treated with Gemzar alone.
At 12 months patients treated with Gemzar-based doublets had a 4% reduced risk of death compared with patients treated with Gemzar alone.
At 18 months patients treated with Gemzar-based doublets had a 3% reduced risk of death compared with patients treated with Gemzar alone.
The researchers concluded that the addition of a second chemotherapy agent to Gemzar provides small but significant improvement in survival compared with Gemzar alone in the treatment of advanced pancreatic cancer. Patients with advanced pancreatic cancer may wish to speak with their physician regarding their individual risks and benefits of all available therapies.

more about many kinds of cancer see >> http://symptom-cancer.blogspot.de/

I had found this site >> http://forums.xisto.com/no_longer_exists/


This website is for people who want to learn Java Programming Language step by step.

This website also includes JAVA lessons from the beginning to advanced level. So this site appropriates for the beginner of Java programmer language or non-basic Java Programming Language.


The lessons are easy to follow and understand starting from how to get your PC JAVA ready, the fundamental programming concept and creating the real application. Moreover, the working examples are also included.



Please enjoy the lessons !!



LESSONS Guidelines :

Lesson 1 Introduction
Lesson 2 Fundamental Programming Concept
Lesson 3 Decisions
Lesson 4 Applets and Graphics
Lesson 5 Introduction to Classes
Lesson 6 Methods
Lesson 7 Arrays and Vectors
Lesson 8 Inheritance and Interfaces
Lesson 9 Streams and Exceptions
Lesson 10 Event Handling

http://pink-ipod-nano.blogspot.de/



Everything about Pink iPod nano, Pink iPod Accessories, etc.

including pink iPhone too